OAS1蛋白单克隆抗体的制备及其表征

中国生物工程杂志

2011, Vol. 31

Issue (10): 7-11

研究报告

OAS1蛋白单克隆抗体的制备及其表征

李孜¹, 包欣晨¹, 高向东¹, 陆小冬², 徐晨²

1. 中国药科大学生命科学与技术学院南京 210009;
2. 北京三元基因工程有限公司北京 102600

Production and Characterization of Anti-OAS1 Monoclonal Antibody

LI Zi¹, BAO Xin-chen¹, GAO Xiang-dong¹, LU Xiao-dong², XU Chen²

1. College of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China;
2. Beijing Tri-Prime Genetic Engineering Incorporated, Beijing 102600, China

全文: PDF(602 KB) HTML

摘要：

目的:用OAS1蛋白免疫小鼠,获得OAS1特异性单克隆抗体,为OAS1的含量测定提供基础。方法:通过全基因合成的方法获得目的基因序列,转化大肠杆菌BL21细胞诱导His-OAS1及OAS1蛋白表达,纯化后用作抗原免疫小鼠,取脾融合,筛选稳定分泌抗体的阳性细胞株,制备并纯化单抗,通过SDS-PAGE,ELISA,Western blot等方法进行检测。结果:体外高效表达OAS1蛋白,并成功制备特异性单克隆抗体,效价在5×10^-11mol/L以上,亲和常数为3.37×10⁸ L·mol^-1。结论:获得高亲和力OAS1单克隆抗体,为其含量的检测奠定了基础。

关键词： OAS1; 细胞融合; 单克隆抗体

Abstract:

Aim: To detect OAS1, its monoclonal antibody was prepared by immune mouse. Methods: BALB/c female mice were immunized with His-OAS1 expressed by E.coli BL21 cells. Monoclonal antibody (McAb) was prepared by hybridoma technology. Identify the purity and characteristics of the selected McAb purified with saturated ammonium sulfate and give preliminary evaluation of the effectiveness of its application, in which SDS-PAGE, ELISA, Western blot and other methods were used. Results: High efficient expression of OAS1 protein in vivo, a McAb can detect the OAS1 was obtained designated as C24-5. The titer of C24-5-McAb was over 9×10^-10mol/L, and the affinity constant of C24-5-McAb was 7.66×10⁷ L·mol^-1. Conclusion: The preparation of C24-5-McAb is very important to further improve the detection of OAS1.

Key words: OAS1 Cell fusion Monoclonal antibody

收稿日期: 2011-05-03 出版日期: 2011-10-25

ZTFLH:

Q819

通讯作者: 徐晨 E-mail: xuchen@triprime.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

李孜, 包欣晨, 高向东, 陆小冬, 徐晨. OAS1蛋白单克隆抗体的制备及其表征[J]. 中国生物工程杂志, 2011, 31(10): 7-11.

LI Zi, BAO Xin-chen, GAO Xiang-dong, LU Xiao-dong, XU Chen. Production and Characterization of Anti-OAS1 Monoclonal Antibody. China Biotechnology, 2011, 31(10): 7-11.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I10/7

[1] Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol, 2005, 5 (3): 215-229.

[2] Gish R G. Current treatment and future directions in the management of chronic hepatitis B viral infection. Clin Liver Dis, 2005, 9 (4): 541-565.

[3] Chebath J, Benech P, Hovanessian A, et al. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem, 1987, 262 (8):3852-3857.

[4] Hovanessian A G, Svab J, Marié I, et al. Characterization of 69-and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells. J Biol Chem, 1988, 263(10):4945-4949.

[5] Hovanessian A G. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases. J Interferon Res, 1991,11(4):199-205.

[6] Silverman R H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol, 2007, 81(23):12720-12729.

[7] 安萍,秦绍明,杨开宇,等. 慢性乙型肝炎病人注射α-干扰素后2-5AS活性动态变化及其临床意义. 天津医药,1995,23(3):147-149. An P,Qin S M,Yang K Y,et al. Tianjin Medical Journal,1995,23(3):147-149.

[8] Studier F W. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif, 2005, 41(1):207-234.

[9] Beatty J D, Beatty B G, Vlahos W G. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods, 1987, 100(1-2):173-179.

[10] Bingfa X, Qinglin F, Hui H, et al. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo. Pharmacology, 2009, 83(6):323-332.

[11] 吴诗品,苏冬娜.CHB患者PBMC中2-5AS基础活性对IFNα信号分子改变的影响.中华微生物学和免疫学杂志,2006,26(11):1026-1030. Wu S P,Su D N. Chinese Journal of Microbiology and Immunology,2006,26(11):1026-1030.

[1]	赵妍淑,张金华,宋浩. 工程原核生物和酵母菌中生产单克隆抗体和抗体片段研究进展 ^*[J]. 中国生物工程杂志, 2020, 40(8): 74-83.
[2]	王猛,宋慧茹,程雨洁,王毅,杨波,胡征. 以核糖体蛋白L7/L12为分子标志物精准检测肺炎链球菌的研究 ^*[J]. 中国生物工程杂志, 2020, 40(4): 34-41.
[3]	孔建涛,庄英萍,郭美锦. 基于DOE设计和氨基酸补加策略提高CHO细胞表达抗CD20单克隆抗体^*[J]. 中国生物工程杂志, 2020, 40(12): 41-48.
[4]	吝建华,韩君,徐寒梅. PD-1/PD-L1免疫检查点抗体药物制剂稳定性开发[J]. 中国生物工程杂志, 2020, 40(10): 35-42.
[5]	江一帆,贾宇,王龙,王志明. 细胞培养过程对单克隆抗体糖基化修饰的影响和调控[J]. 中国生物工程杂志, 2019, 39(8): 95-103.
[6]	高倩,江洪,叶茂,郭文娟. 全球单克隆抗体药物研发现状及发展趋势 ^*[J]. 中国生物工程杂志, 2019, 39(3): 111-119.
[7]	刘国芳,刘晓志,高健,王志明. 宿主细胞残留蛋白质对单克隆抗体药物质量影响及其质量控制 ^*[J]. 中国生物工程杂志, 2019, 39(10): 105-110.
[8]	徐婧雯,张雪梅,吴忠香,朱文兵,蒋曦,巩蔚,严丽蔚,宋杰,李慧,董少忠. 抗树鼩CD3ε单克隆抗体的制备及生物学特性鉴定[J]. 中国生物工程杂志, 2018, 38(4): 54-62.
[9]	任建委,李军,李尚泽. 人源CT55蛋白原核表达及单克隆抗体的制备 ^*[J]. 中国生物工程杂志, 2018, 38(11): 1-8.
[10]	毛开云,范月蕾,王恒哲,王跃,陈大明. 全球PD-1/PD-L1单克隆抗体市场竞争格局 ^*[J]. 中国生物工程杂志, 2018, 38(11): 103-115.
[11]	孙静静,周伟伟,周雷鸣,赵巧辉,李桂林. 杂交瘤细胞体外大规模培养研究进展[J]. 中国生物工程杂志, 2018, 38(10): 82-89.
[12]	王云龙, 赵二霞, 李玉林. Thymidine Kinase 1(TK1)重组蛋白的表达、纯化及鉴定[J]. 中国生物工程杂志, 2017, 37(9): 15-22.
[13]	吴孟玲, 周嘉旺, 杜军. Nodal检测双单抗夹心ELISA法建立及应用[J]. 中国生物工程杂志, 2017, 37(3): 51-57.
[14]	李敏, 吴日伟. 国内外单抗药物市场概述[J]. 中国生物工程杂志, 2017, 37(3): 106-114.
[15]	邓义熹, 李继东, 李乐, 蒙国基, 于玉根. 添加SNS能显著提高CHT填料使用寿命的研究[J]. 中国生物工程杂志, 2017, 37(1): 81-88.

Viewed

Full text

Abstract

Cited

Shared

Discussed